These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21548722)

  • 1. Cilostazol in patients with ischemic stroke.
    Al-Qudah ZA; Hassan AE; Qureshi AI
    Expert Opin Pharmacother; 2011 Jun; 12(8):1305–1315. PubMed ID: 21548722
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.
    Shinohara Y
    Cerebrovasc Dis; 2006; 22(1):57-60. PubMed ID: 16645267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cilostazol].
    Inoue T
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():393-9. PubMed ID: 27534202
    [No Abstract]   [Full Text] [Related]  

  • 4. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet/von Willebrand factor inhibitors to the rescue of ischemic stroke.
    Mannucci PM
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1882-4. PubMed ID: 20844269
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: protective effects of antiplatelet agents against stroke.
    Shimazawa M; Hara H
    J Pharmacol Sci; 2011; 116(1):30-5. PubMed ID: 21498958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol improves endothelial function in patients with ischemic stroke: A randomized controlled single-center study with flow-mediated dilation technique.
    Shirai Y; Toi S; Adachi U; Tsutsumi Y; Kitagawa K
    J Neurol Sci; 2022 Aug; 439():120318. PubMed ID: 35749837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].
    Ishiguro M; Hara H
    Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premorbid antiplatelet use and ischemic stroke outcomes.
    Li HF; Pan XD
    Neurology; 2006 Nov; 67(9):1723; author reply 1723. PubMed ID: 17101925
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 14. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 15. Tailoring antiplatelet therapy in acute coronary syndromes: the thin red line.
    Vieira MS
    Cardiology; 2013; 126(4):230-2. PubMed ID: 24081218
    [No Abstract]   [Full Text] [Related]  

  • 16. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice. Acute ischemic stroke.
    van der Worp HB; van Gijn J
    N Engl J Med; 2007 Aug; 357(6):572-9. PubMed ID: 17687132
    [No Abstract]   [Full Text] [Related]  

  • 19. Commencing antiplatelet therapy in older people after an acute ischaemic stroke.
    Fletcher EH; Newton JL; Gray CS
    Age Ageing; 2009 Mar; 38(2):142-4. PubMed ID: 19147738
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives.
    Takagi T; Hara H
    J Pharmacol Sci; 2016 Jul; 131(3):155-61. PubMed ID: 27381422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.